This webinar described the benefits of using FAIR approaches in data handling, where results from your studies are made Findable, Accessible, Interoperable and Reusable. The "ins and outs" of working with data were described and how teams can establish a streamlined analysis workflow in the projects. The group also demonstrated the GRIT42 software tool which […]
Virtual closed meeting for IMI AMR Accelerator partners to get up to speed with the most novel developments from the Consortium's projects. About this Event IMI AMR Cross-Pillar Meeting (invitation only) This was an online meeting where partners were introduced to the AMR Accelerator projects and heard from Dr Timothy Rawson, Honorary Clinical Research Fellow, […]
Join online over 400 international AMR experts for a week-long learning and networking experience. The 4th AMR conference is the one-stop-shop for all AMR stakeholders from industry, SMEs, start-ups, big pharma, academia, clinics, regulatory bodies, investors, public institutions and policy to discuss all relevant challenges of bringing new antimicrobial treatments and diagnostics in the market. […]
This webinar provided an overview of animal infection models commonly used for studies of antibiotics against gram-negative bacteria. The webinar was driven by the COMBINE objective to harmonse and standardise a protocol for a mouse infection model used for efficacy and PKPD studies. The infection model was validated through well-characterised bacterial strains and control compounds […]
December 3, 2020, 3.30PM-4.30PM CET Peter Warn is an experienced antimicrobial discovery scientist and consultant with a long and successful record of working in the anti-infective discovery industry. His expertise goes from antimicrobial development (antibacterial, anti-fungal, anti-parasitic and anti Mtb), including in vitro, and animal models from basic models through to PKPD and assisting in […]
The webinar covered processes for working with aggregated clinical data in the COMBINE consortium and AMR Accelerator. Firstly, the team outlined a set of procedures established for assessing the ethical status of data sets from external organisations. Then, the team described data formats and standards for working with clinical data sets uploaded into the GRIT42 […]
This workshop provided an open discussion forum to identify, propose and prioritise specific challenges, success and risk factors in the development of vaccines against nosocomial AMR pathogens. Participants included experts in clinical vaccine development from industry, academia and regulatory agencies, as well as experts in innovative clinical trial designs. General discussion topics covered pre-existing clinical […]
